The enemy of knowledge is not ignorance, it’s the illusion of knowledge (Stephen Hawking)

It ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so (Mark Twain)

Invest with smart knowledge and objective odds

THE DAILY EDGE: 10 NOVEMBER 2020

Pfizer Vaccine: What You Need to Know

(…) “It seems to be a proof of principle that we can make a vaccine, that it can make an immune response, that it does look safe in individuals that have been studied so far and that it actually works in the real world to protect against Covid,” said Dr. Buddy Creech, director of the Vanderbilt Vaccine Research Program in Nashville, Tenn., said in an interview. “That’s all you can hope for in any vaccine. And for it to have occurred this quickly and this rigorously is really encouraging.” (…)

The analysis took place too soon for researchers to figure how long the protection conferred by the vaccine will last; the data only looked how well the vaccine worked seven days after subjects got a second shot. (…) “Is this going to be a handful of months, like the flu vaccine? Is it going to be like measles or smallpox where it’s lifelong immunity?” It also is unclear whether the vaccine worked at protecting against severe Covid-19 disease. Nor is it clear whether the vaccine worked in all the different populations that would be in line to get one, including the elderly, children and various racial and ethnic groups. Pfizer and BioNTech are expected to release additional data later.

  • “The results are really quite good, I mean extraordinary,” said Dr. Anthony Fauci.
  • More than a dozen economies have inked supply deals with Pfizer and BioNTech for their vaccine. The duo expects to be able to produce 1.3 billion doses of their shot, enough for 650 million people, by the end of 2021. About 50 million doses are expected to be available this year. (Bloomberg)
  • The U.S. government has already purchased 100 million doses, with an option to buy another 500 million. That could theoretically cover America’s 255 million adults, and most of those under 18. (Axios)

France, Germany, Italy?…

Eli Lilly’s Covid-19 Antibody Drug Gets FDA Green Light Authorization of the drug addresses a hole in Covid-19 treatment, providing options for the infected before they require hospitalization

The U.S. Food and Drug Administration said Eli Lilly LLY -0.29% & Co.’s antibody drug should be used for patients ages 12 and up with mild to moderate Covid-19, based on a study showing it helped improve symptoms and kept many patients out of the hospital.

The FDA said the drug is authorized for patients at high risk of progressing to severe Covid-19, including people 65 and older, or who have certain chronic medical conditions. The drug shouldn’t be given to hospitalized patients, the FDA said, because it showed no clinical benefit in a study among such patients. (…)

Brazil Suspends Trials of Chinese Vaccine The clinical trials were halted following a ‘severe adverse event’

(…) Sinovac said in a statement Tuesday that it was still confident in the safety of the vaccine and that it was in contact with Butantan, which told the firm that it doesn’t believe the event is related to the vaccine. Sinovac spokesman Liu Peicheng said it hasn’t found any adverse cases in other ongoing trials for the vaccine. (…)

unnamed (95)Data: Our World in Data; Chart: Naema Ahmed/Axios

Small Business Optimism Remains Steady in October, but Owners’ Uncertainty Increased

The NFIB Optimism Index remained at 104.0 in October, unchanged from September and a historically high reading. Four of the 10 components improved, 5 declined, and 1 was unchanged. Although all of the data was collected prior to Election Day, a 6-point increase in the NFIB Uncertainty Index to 98 was likely driven by the election and uncertain conditions in future months due to the COVID-19 pandemic and possible government mandated shutdowns. The uncertainty reading was the highest reading since November 2016.

image

image

image

Small business owners uncertain of survival without new stimulus

The positive news about a possible coronavirus vaccine could prove to be a negative for many struggling small business owners, as economists worry that it could reduce the urgency for Congress to pass a new fiscal relief package.

A new survey from Goldman Sachs through its 10,000 Small Businesses program provided first to Axios finds that more than half of small business owners (52%) have stopped paying themselves in a bid to keep their businesses afloat and four in 10 (42%) already have begun laying off employees or cutting worker pay.

  • 33% have dipped into personal savings to stay operational.
  • 28% say the legislative uncertainty has caused them to consider closing their business.

Moving forward, 38% of those surveyed said they will have to lay off more employees or cut employee compensation and 20% said they will not be able to pay their commercial rent through the end of the year without additional help from Congress. (…)

unnamed (97)

China consumer price inflation hits lowest level in more than a decade Official data raise spectre of deflation in wake of Covid-19 pandemic

The consumer price index rose 0.5 per cent year-on-year in October, official data show, lower than economists’ expectations of 0.8 per cent. That compared to a 1.7 per cent rise in September and 2.4 per cent in August. (…)

Core CPI inflation, which excludes food and energy, was 0.5 per cent in October and has remained at that level — its lowest since 2010 — for several months. (…)

ANOTHER CHANGE IN LEADERSHIP?

Yesterday, stocks closed well off their best levels. DJIA +2.95%, S&P 500 +1.17%, NASDAQ -1.52%, S&P 600 +4.88%.

Energy and Financials won big from their bottom of the 2020 performance ranks. The potential vaccine could change the narrative away from “tech companies are the only growers during a pandemic” to a “back to normal, where’s growth at a reasonable price” market.

spy

rsp

unnamed (96)

Reproduced from Charles Schwab; Chart: Axios Visuals

  • The 30-company Dow was boosted by Disney, Boeing and Chevron, which each gained more than 11% on the day. The tech-heavy Nasdaq had its worst day since Oct. 30 and was led downward by companies like Netflix, which fell by around 9%, as well as Zoom and Peloton, which both declined by almost twice that much on the day.

  • Value and cyclical stocks outperformed growth and momentum stocks by the most in a single session since 2000 by some measures, according to FactSet. (Axios)

Not meaty enough: Beyond Meat shares fell by as much as 27% in after-hours trading after releasing underwhelming earnings that showed the company returning to a quarterly net loss and revenue that badly missed expectations. (CNBC)

U.S. vs. China in 5G: The Battle Isn’t Even Close China is leading the way in the size and consistency of its 5G network

China has more 5G subscribers than the U.S., not just in total but per capita. It has more 5G smartphones for sale, and at lower prices, and it has more-widespread 5G coverage. Connections in China are, on average, faster than in the U.S., too. (…)

Where China has a definite edge is in the nuts and bolts of 5G. By year’s end, China will have an estimated 690,000 5G base stations—boxes that blast 5G signals to consumers—up and running across the country, compared with 50,000 in the U.S., according to Handel Jones, chief executive of International Business Strategies Inc., a research firm. (…)

In China, 5G phones are less expensive, too: $458, on average, in the second quarter of this year, compared with $1,079 in the U.S., according to Canalys. (…)

The top-down approach has led to a more uniform version of 5G throughout the country, compared with the U.S., and more consistent speeds, says Wayne Lam, director of research at CCS Insight. “There’s a lot more central planning” behind China’s approach, Mr. Lam says.

The U.S., by contrast, has more-fragmented 5G coverage and uneven speeds. For example, while superfast 5G known as “millimeter wave” exists in a few crowded hot spots, like stadiums—and is not yet available to consumers in China—5G is slower everywhere else in the U.S.

(…) China’s 5G network covers only 8% of the population. In South Korea, by comparison, 5G covers 25% of the population, said Mr. Ding, who added that China’s 5G network is also slower than those of South Korea, Switzerland and other countries. (…)

“At present, China has built the world’s largest 5G network,” Mr. Ding said. However, he added, when compared with South Korea, Switzerland and a handful of other countries on the cutting edge of 5G, China still has room for improvement. (…)

Boeing Jets, Other U.S. Goods Worth $4 Billion Face EU Tariffs The European Union will impose tariffs on $3.99 billion of Boeing jets and other U.S. goods annually as part of a long-running trade dispute, the bloc’s trade chief said.
Silicon Valley Gets Another President Skeptical of Big Tech As a candidate, Joe Biden lambasted Facebook for what he considered failures to contain the spread of misinformation. His presidential election win puts him in a position to do something about it.
Amazon Faces New EU Antitrust Charges Amazon.com faces a fresh legal battle with the European Union, with the bloc set to file formal charges against the online retailer for alleged unfair business practices Tuesday, according to a person familiar with the matter.

Election latest. Attorney General William Barr authorized the DOJ to open probes into potential irregularities, while acknowledging there’s no conclusive evidence. His elections crime chief Richard Pilger quit in response, saying the move “abrogated the forty-year-old non-interference policy.” Joe Biden’s team threatened legal action if the White House doesn’t declare him the winner. (Bloomberg)

imagehttps://bit.ly/2020-Elections-Mehlman

THE DAILY EDGE: 13 APRIL 2020

Virus Update

Everything is flattening…

image

image

…even testing…

image

A graphic with no description

image

image

 image image

  • China reported an additional 108 cases for April 12, of which 98 were from overseas, according to the National Health Commission. There were 61 asymptomatic cases. China has 1,064 asymptomatic coronavirus cases under medical observation as of April 12.
  • Japan urges public to reduce social contacts by 80% Experts fear half-measures could hurt the economy without stopping spread of coronavirus
  • Spain reported the smallest number of new coronavirus infections since March 20 on Monday and saw the daily death toll decrease.
  • WHO says 70 vaccines are in development. The furthest along in the clinical process is an experimental vaccine developed by Hong Kong-listed CanSino Biologics Inc. and the Beijing Institute of Biotechnology, which is in phase two. The other two being tested in humans are treatments developed separately by U.S. drugmakers Moderna Inc. and Inovio Pharmaceuticals Inc., according to a WHO document.
  • Pfizer Inc. has found a promising but early potential coronavirus treatment, which the drugmaker aims to begin testing in patients this summer.
  • Chinese Doctors at Coronavirus Hub Say Evidence on Chloroquine Is Inconclusive Chinese doctors who have for months treated patients on the front lines of China’s fight against the new coronavirus offered a sobering assessment of the potential treatments, saying they hadn’t seen clear evidence that drugs such as chloroquine were effective.

“There’s no scientific conclusion.” (…)

The doctors also cautioned that some recovered patients had tested positive again, while expressing concern about asymptomatic cases, dozens of which have been disclosed in recent days across China. (…)

Chloroquine has been the subject of fierce debate within the U.S. administration. President Trump has at times touted it as a remedy and in recent days he has advised even those without symptoms to take the drug. That has come in defiance of advice from public health experts and some of his own medical advisors. (…)

A study published last month in the New England Journal of Medicine, based on a test on severe coronavirus cases at Jinyintan, concluded that Kaletra wasn’t effective. But Jinyintan’s Dr. Zhang said supplementary data in the study suggested it had potential. (…)

Fed Heeds Bagehot: Lending to ‘This Man and That Man’

(…) Now the Fed is devising new tools, relying on the advice of British journalist Walter Bagehot, author of an 1873 book that central bankers still use as a guide for crisis management: “The holders of the cash reserve must be ready not only to keep it for their own liabilities, but to advance it most freely for the liabilities of others,” Bagehot wrote. “They must lend to merchants, to minor bankers, to ‘this man and that man,’ whenever the security is good.”

For the Fed on Thursday, “this man and that man” was expanded to include:

  • Some riskier classes of corporate debt beyond the investment-grade space.
  • The highest-rated tranches of existing commercial mortgage-backed securities and newly issued collateralized loan obligations.
  • Short-term debt from states, counties and cities.

Mr. Powell deflected worries that the expansion of credit by the Fed would lead to inflation. “I worry that in hindsight, you will see that we could have done things differently. But one thing I don’t worry about is inflation right now,” he said.

(…) “We will continue to use these powers forcefully, proactively, and aggressively until we are confident that we are solidly on the road to recovery,” Mr. Powell said in remarks at an online forum hosted Thursday by the Brookings Institution in Washington. (…)

“All of us are affected, but the burdens are falling most heavily on those least able to carry them,” he said. “As a society, we should do everything we can to provide relief to those who are suffering for the public good.” (…)

Mr. Powell also said the U.S. needed a national plan for reopening the economy based on the best analysis from health officials. “We all want it to happen as quickly as possible. We all want to avoid a false start,” he said. (…)

EU Finance Ministers Agree to Funding to Cushion Virus Impact Officials worked through deep differences to agree to a package of measures totaling half a trillion euros aimed at blunting the coronavirus crisis, officials said. But a bigger conflict over whether to share the costs was deferred.

(…) Under the deal, member states will be able to receive precautionary credit lines from the region’s bailout fund amounting to at least 2% of a country’s economic output, or some €240 billion ($262 billion) of the available credit in the region’s bailout fund, known as the European Stability Mechanism. (…)

The finance ministers also backed a program extending up to €200 billion in loans to EU businesses, underwritten by €25 billion in member state guarantees for the European Investment Bank, the bloc’s finance arm.

They gave the go-ahead for a €100 billion jobs support program proposed last week by the European Commission. Once set up, that will see the EU’s executive body borrow directly in the markets, with guarantees provided by member states, to help governments fund programs that prevent companies laying off workers. (…)

But southern countries say immediate guarantees of common debt issuance are crucial to allow them to spend what they need to handle the coronavirus crisis. Without that promise, governments in the hardest hit countries may constrain stimulus now to avoid high debt level spiraling further and sparking a sovereign debt crisis as the bloc looks toward an economic recovery. (…)

It said only that discussions on financing the fund would include “innovative financial instruments, consistent with EU Treaties.” The Netherlands, Germany, Finland and others have long opposed Eurobonds, saying they would turn the eurozone into a financial transfer union and are inconsistent with EU and domestic laws. (…)

Carsten Brzeski, Chief Economist, Eurozone and Global Head of Macro at ING, said that given the disagreements, he doubts the recovery fund will “fly any time soon.”

“This aid package…leaves the question whether any of the countries will be satisfied,” he said. “As so often in eurozone decision making, small historic steps have been taken toward more integration, but many would argue this isn’t yet enough.”

U.S. Consumer Price Index Declines and Core Prices Slip

The CPI fell during March by the largest amount since January 2015. Consumer prices were off 0.4% (+1.5% y/y) following two consecutive 0.1% increases. The CPI excluding food & energy slipped 0.1% (+2.1% y/y) last month after two months of 0.2% increase. (…)

Goods prices excluding food & energy moved 0.3% lower (-0.2% y/y) following a 0.2% rise. The decline was led by a 2.0% fall (-1.6% y/y) in apparel prices. (…) Services prices were little changed (2.8% y/y). (…)

 large image large image

China consumer price growth slows after hitting 8-year high Lower inflation suggests goods supply is increasing while factory gate prices fall
WeWork’s lessons for US real estate The company’s troubles hint of what is to come — a long period of falling property prices in global cities
China’s Car Sales Improved in March

Sales last month were down 43% from a year earlier, the government-backed China Association of Automobile Manufacturers said Friday, an improvement on February’s 79%. There were 1.43 million vehicles sold nationally. Sales in the first quarter as a whole were off 42%, to 3.67 million vehicles.

Tesla expands locally made line-up, blunting trade war impact

U.S. electric vehicle maker Tesla Inc (TSLA.O) said on Friday it has started China sales of two more Model 3 variants built at its Shanghai plant, meaning all Model 3 sedans sold in the country are now locally made and not subject to import tax. (…)

The move contrasts with a previous plan from Tesla’s billionaire chief executive, Elon Musk, under which the automaker would only make more affordable versions of the Model 3 sedan at its $2 billion Shanghai factory. (…)

Japan to pay firms to leave China, relocate production elsewhere as part of coronavirus stimulus Japan has earmarked US$2.2 billion of its record economic stimulus package to help its manufacturers shift production out of China

(…) The government’s panel on future investment last month discussed the need for manufacturing of high-added value products to be shifted back to Japan, and for production of other goods to be diversified across Southeast Asia. (…)

A February survey by Tokyo Shoko Research found 37 per cent of the more than 2,600 companies that responded were diversifying procurement to places other than China amid the coronavirus crisis. (…)

THE OIL SLICK
U.S., Saudi Arabia, Russia Lead Pact for Record Oil Cuts Twenty-three countries committed to withhold 9.7 million barrels a day of oil collectively from global markets. The deal, designed to address a mounting glut, came as President Trump intervened to help resolve a Saudi-Mexico standoff.

As part of the agreement, 23 countries committed to withhold collectively 9.7 million barrels a day of oil from global markets. (…) Under the final deal disclosed Sunday, Mexico will cut 100,000 barrels a day of output, some 250,000 barrels fewer than Saudi Arabia initially wanted. The U.S. unlocked the standoff by pledging to compensate for the Mexican amount with 300,000 barrels of reductions of its own, the delegates were told. It couldn’t be determined whether that was in addition to other U.S. cuts, or how the U.S. cuts would be implemented. (…)

The U.S., Canada, Brazil and the other Group of 20 leading economies that aren’t part of the OPEC alliance will hold back four million to five million barrels a day, OPEC said in a draft press release.

Canada wasn’t asked to impose production cuts on its oil producers, said Sonya Savage, energy minister for Alberta, Canada’s largest oil-producing province. Instead, the decrease will come through market forces, as companies tend to cut production voluntarily when prices drop, she said.

In addition, Saudi Arabia, the United Arab Emirates and Kuwait have agreed to cut a combined two million barrels a day above their quota, Iranian Oil Minister Bijan Zanganeh said in a televised interview.

Industrialized nations that are part of the International Energy Agency are set to announce crude purchases to fill their national inventories as a way to take some surplus oil off the market, according to people familiar with the matter.

Overall, the measures, combined with existing sanctions on Iran and Venezuela and outages in hot spots such as Libya, could withhold 20 million barrels a day of supplies from the market, OPEC said in the draft press release. (…)

Some Republican senators spoke with the Saudi energy minister for nearly two hours Saturday, warning him a longstanding U.S. alliance with the kingdom would be damaged if he didn’t cut output. “The Saudis spent over a month waging war on American oil producers, all while our troops protected theirs. That’s not how friends treat friends,” Sen. Kevin Cramer, a North Dakota Republican, said. (…)

There are so many ways to do the math for this “deal”. The official version is a 9.7 mb/d cut. But, as Goldman says

Taking into account updated core-OPEC production guidance from April, this 9.7 mb/d “headline” deal represents a 12.4 mb/d cut from claimed April OPEC+ production (given the Saudi, UAE, Kuwait ongoing surge) but an only 7.2 mb/d cut from 1Q20 average production levels.

Then the G20 seems to have agreed to reductions in output of 3.7 mb/d, mainly from the U.S., Brazil and Canada, but the figure was 5 mb/d on Friday and 4 to 5 mb/d yesterday morning…some pipelines must be leaking somewhere…and these are eventual total reductions due to market forces…So

Given the difficulty for most producers outside of core-OPEC to implement large cuts, today’s agreement leaves the voluntary cuts as still too little and too late to avoid breaching storage capacity, ensuring that low oil prices force all producers to contribute to the market rebalancing. Ultimately, this simply reflects that no voluntary cuts could be large enough to offset the 19 mb/d average April-May demand loss due to the coronavirus. We therefore reiterate our view that inland crude prices will decline further in coming weeks as storage capacity becomes saturated and expect further weakness in WTI timespreads and crude prices in coming weeks, as already presaged on Friday, with downside risks to our short-term $20/bbl forecast.

The U.S. is said to have saved the deal by pledging to make up some 250,000 barrels a day of cuts demanded of OPEC+ member Mexico with U.S. reductions. But GS explains that

In fact, the US SPR may be how the reduced 300 kb/d Mexico’s cut are allocated as its caverns cannot mix sweet and sour crude, with 85% of the current spare capacity only suitable for sour (and not shale) purchases (Mexico in fact already accounts for the largest historical source of US SPR crude).

The other story in the saga comes from Bloomberg:

(…) With markets collapsing, Putin agreed to cut more than 2.5 million barrels a day of crude from the 11 million of combined crude and condensate Russia pumps each day, more than four times the reduction that he turned down in early March and more than what Saudi Arabia is obliged to cut from its output level last month.

If the cuts are achieved, Russia’s output for the next two months will drop to the annual average last seen in 2003, according to Bloomberg calculations based on data from the Russian Energy Ministry and BP Plc’s Statistical Review. Russia agreed to continue smaller cuts until May 2022, though it did manage to hold onto one concession by keeping condensate, a light fuel of which it is a major producer, out of the quotas.

Moscow’s climbdown marks a dramatic role reversal. Due to climate and geography, Saudi Arabia can turn the taps on and off much more easily than Russia and, until now, Russia had dawdled on cuts, avoiding full compliance while Saudi Arabia bore the brunt of the output curbs to maintain market stability. (…)

Don’t count Putin out, he is also pretty slick. Russia meeting its quota would be a first. It has also always refused to disclose the data on its condensate production…

SENTIMENT WATCH
Goldman Says U.S. Stocks Have Likely Bottomed Unprecedented policy support and a flattening viral curve have “dramatically” cut risks, the bank says.

If the U.S. doesn’t have a second surge in infections after the economy reopens, equity markets are unlikely to make new lows, they said. (…) “These policy actions mean our previous near-term downside of 2,000 is no longer likely” for the S&P 500 Index. (…)

“Despite the likely steady stream of weak earnings reports, 1Q earnings season will not represent a major negative catalyst for equity market performance,” they wrote. “Our year-end S&P 500 target remains 3,000.”

David Kostin also wrote:

It is remarkable that the US is in the midst of its greatest economic crisis in nearly a century and unprecedented societal disruption while the stock market trades at the same level as it did in June 2019, just 10 months ago. At that time, our top-down EPS estimate for 2020 was $174; today it is 37% lower at $110. The path to earnings normalization is everyone’s focus. At 2790, S&P 500 trades at 16x our baseline 2021 EPS estimate of $170 and 24x our downside scenario of $115.

(…) the index level and consensus 2021 EPS forecast of $177 equate to a P/E multiple of 16x. If consensus EPS forecasts are revised lower, as we expect, the implied market multiple will become even more elevated. Put differently, our macro valuation model indicates that either the S&P 500 index should be 25% lower, consensus 2021 EPS should be 25% higher, or that equity valuations today are tied more closely to policy support and investor sentiment than to the traditional drivers captured in our model.

Kostin adds that “the market’s sharp rally makes clear the importance of risk sentiment in driving equity prices.” Here’s Ed Yardeni’s rendering of sentiment:

image

THE RULE OF 20 STRATEGY

The Rule of 20 Strategy allocates cash based on the Rule of 20 P/E and the trend in the Rule of 20 Fair Value, only using known trailing data. Be warned that at today’s opening of 2765, the R20 P/E is 19.3 based on trailing EPS of $160.30 which will most likely drop rapidly as Q1’20 results start coming in this week.

This is only 3.6% away from 20.0 which would trigger a move to 40% cash from the current 0% set March 16 at 2405.

image

Other charts FYI:

relates to Markets Are Rising on Another Faustian Bargain

Number of U.S. Corporate Insiders Buying Stock by Month
U.S. Officials Target Chinese State-Owned Telecom Provider Trump administration officials sought to revoke federal licenses used by China Telecom to do business in the U.S., ratcheting up pressure on a state-owned enterprise close to Beijing.
Coronavirus Coverage. In China, It’s Easy to Get. Insurance companies in China are taking on an unusual mission: They are promising to cover business losses from the coronavirus pandemic as hundreds of millions of people return to work and the country tries to rev up its economic engine.

Since February, dozens of Chinese property-and-casualty insurers have rolled out new policies or expanded existing ones to provide compensation when workers contract Covid-19, the respiratory disease caused by the new coronavirus.

The insurance payouts would help companies that are forced to close temporarily if staffers fall sick, other employees have to be quarantined and business activities are disrupted.

Some of the policies are provided free-of-charge by insurers, while others have low premiums that are subsidized by local governments. Many sellers of coronavirus-related coverage are state-owned insurers, which can likely fall back on state support in the event of major losses. (…)

Dozens of local governments have pledged to foot between 50% and 70% of the policy premiums. Some have asked companies to band together to sign up for group policies at better rates. (…)

Many policies are tailored for small businesses that have been among the hardest hit as revenues have stalled, and are provided at no cost to them. (…)

Mobile payments giant Alipay is offering a business-interruption policy, also at no cost, with a maximum daily payout of 800 yuan for 14 consecutive days for companies that employ no more than 20 people. The policy has a duration of 60 days. (…)